Karyopharm to present selinexor data at the 2023 international myeloma society annual meeting and european society of gynaecological oncology 2023 annual meetings

Newton, mass. , sept. 26, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected to be presented at the 2023 international myeloma society (ims) annual meeting, being held september 27-30 in athens, greece.
KPTI Ratings Summary
KPTI Quant Ranking